Ever Supreme Bio Technology | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

23,996 results for “Ever Supreme Bio Technology”

Trials

View all 8750 →

Avazzia HVPC Bio-Electrical Stimulation Technology (BEST™) Microcurrent CTS RCT

120 participants · First posted Feb 17, 2020

Laryngeal Mask Airway Supreme Versus Laryngeal Tube

60 participants · First posted Sep 29, 2014

Clinical Performance of Short Fiber Reinforced Resin Composite Versus Indirect Nanohybrid Resin Composite Onlay Restorations.

76 participants · First posted Sep 14, 2017

Drugs

View all 1468 →

ADCV-01

UMSC-01

CIK(Ever Supreme Bio)

Organizations

View all 834 →

EVER SUPREME BIO TECHNOLOGY CO., LTD.

Taiwan

Health Ever Bio-Tech Co., Ltd.

Taiwan

NATURE'S BIO TECHNOLOGY PTY LTD

Australia

News

View all 12944 →

World-First Brain-Targeting Exosome Platform Delivers Curcumin Across Blood-Brain Barrier for Parkinson's Disease

China Medical University Achieves Milestone with CAR001 Cell Therapy for Solid Tumors

Ever Supreme's Allogeneic CAR-T CAR001 Clears Phase I Safety Review, Advances to Phase IIa in Solid Tumors

Page 1 of 2400